Robert Milne > White & Case LLP > New York, United States > Lawyer Profile

White & Case LLP‘s cartel team regularly represents corporates and individuals in high-profile civil and criminal cartel proceedings, including bet-the-company litigation for major pharmacy industry players. Clients from a range of jurisdictions and industries, including life sciences, financial services, and auto parts, seek the firm out for its cartel defense capabilities as well as its expertise in multijurisdictional litigation and investigations. The firm is a litigation powerhouse with a remarkably strong track record in disposing civil and criminal claims in court or on appeal, both in the US and in global cartel cases. The team, based in Washington DC unless otherwise stated, is headed by significantly experienced cartel litigator Mark Gidley. He is supported by Peter Carney, whose practice focuses on healthcare and pharma-related antitrust litigation, as well as Christopher Curran, whose litigation and defense of an amnesty agreement was the first of its kind. Trial attorney J. Frank Hogue is regularly involved in enforcement proceedings and class action defense. Adam Acosta  is a litigator focusing on complex antitrust litigation and government investigations, while New York-based Robert Milne and Raj Gandesha also receive praise for their antitrust expertise.

White & Case LLP houses a broad team which handles pharmaceutical antitrust damages cases, life science M&A and investments, and commercial litigation involving research agreements and contractual breaches. Peter Carney leads the team from Washington DC, drawing on his expertise in acting for domestic and overseas pharmaceutical companies in antitrust civil litigations and government investigations. New York-based antitrust litigator Robert Milne assists pharmaceutical clients with M&A transactions. Colleen Tracy James has since left the practice.